Answer
Although Synjardy (empagliflozin + metformin) has not undergone interaction studies, empagliflozin may increase kidney lithium excretion and lower blood lithium levels; patients should be referred to their lithium prescriber for more frequent serum lithium monitoring after empagliflozin initiation and dose changes.
Sources for this answer
- Synjardy film coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 31Document updated
Sources checked